B7-H3 targeted CAR-T (Eye & Ent Hospital of Fudan University)

B7-H3靶向CAR-T细胞疗法 (复旦大学附属眼耳鼻喉科医院)

Report date: 2026/05/15 20:01:45

Base Information

Drug NameB7-H3 targeted CAR-T (Eye & Ent Hospital of Fudan University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-CD276

TargetsCD276 antigen

Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesEye & Ent Hospital of Fudan University

China Registration ClassN/A

Develop Information

Active CompaniesEye & Ent Hospital of Fudan University

Inactive CompaniesN/A

Active IndicationsSquamous Cell Carcinoma of Head and Neck

Inactive IndicationsN/A

Other Information

ATC CodeN/A